-
Real-Time Tracking and In Vivo Visualization of β‑Galactosidase Activity in C...
Development of “smart” noninvasive bioimaging probes for trapping specific enzyme activities is highly desirable for cancer therapy in vivo. Given that β-galactosidase (β-gal)... -
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage act...
Mebendazole (MBZ), a drug commonly used for helminitic infections, has recently gained substantial attention as a repositioning candidate for cancer treatment. However, the... -
Determinants of Treatment Abandonment in Childhood Cancer: Results from a Glo...
BackgroundUnderstanding and addressing treatment abandonment (TxA) is crucial for bridging the pediatric cancer survival gap between high-income (HIC) and low-and middle-income... -
r37980778c78--a40d986ef1025d19d9685143933b56e4
Using dendrimers in cancer therapy as nonviral vectors for gene delivery seems promising. The biological performance of a dendrimer-based gene delivery system depends heavily on... -
r37980778c78--1a9bb8f6d693363ce2292b689ef658fc
Using dendrimers in cancer therapy as nonviral vectors for gene delivery seems promising. The biological performance of a dendrimer-based gene delivery system depends heavily on... -
Evaluating the Gene-Expression Profiles of HeLa Cancer Cells Treated with Act...
Using dendrimers in cancer therapy as nonviral vectors for gene delivery seems promising. The biological performance of a dendrimer-based gene delivery system depends heavily on... -
r37980778c78--1aa7b53c4572584672cef0a068237f71
Using dendrimers in cancer therapy as nonviral vectors for gene delivery seems promising. The biological performance of a dendrimer-based gene delivery system depends heavily on... -
Informed consent in oncology clinical trials: A Brown University Oncology Res...
BackgroundInformed consent forms (ICFs) for oncology clinical trials have grown increasingly longer and more complex. We evaluated objective understanding of critical components... -
Structural Determinants of p53-Independence in Anticancer Ruthenium-Arene Sch...
p53 is a key tumor suppressor gene involved in key cellular processes and implicated in cancer therapy. However, it is inactivated in more than 50% of all cancers due to... -
r37980778c78--0c1b8fe4eebf4fb6a6cc01afc14a086b
Development of “smart” noninvasive bioimaging probes for trapping specific enzyme activities is highly desirable for cancer therapy in vivo. Given that β-galactosidase (β-gal)...